To monitor the effect of 8CPT on angiogenesis in the prostate tumors, formalin-fixed tumor slices were immunostained with antibodies to CD31 and VEGF, an endothelial cell marker and a proangiogenic factor, respectively. Here, PECAM1 is linked to neoplasm.